These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

237 related items for PubMed ID: 36002548

  • 1. Safety evaluation of β-nicotinamide mononucleotide oral administration in healthy adult men and women.
    Fukamizu Y, Uchida Y, Shigekawa A, Sato T, Kosaka H, Sakurai T.
    Sci Rep; 2022 Aug 24; 12(1):14442. PubMed ID: 36002548
    [Abstract] [Full Text] [Related]

  • 2. The efficacy and safety of β-nicotinamide mononucleotide (NMN) supplementation in healthy middle-aged adults: a randomized, multicenter, double-blind, placebo-controlled, parallel-group, dose-dependent clinical trial.
    Yi L, Maier AB, Tao R, Lin Z, Vaidya A, Pendse S, Thasma S, Andhalkar N, Avhad G, Kumbhar V.
    Geroscience; 2023 Feb 24; 45(1):29-43. PubMed ID: 36482258
    [Abstract] [Full Text] [Related]

  • 3. Ingestion of β-nicotinamide mononucleotide increased blood NAD levels, maintained walking speed, and improved sleep quality in older adults in a double-blind randomized, placebo-controlled study.
    Morifuji M, Higashi S, Ebihara S, Nagata M.
    Geroscience; 2024 Oct 24; 46(5):4671-4688. PubMed ID: 38789831
    [Abstract] [Full Text] [Related]

  • 4. Oral Administration of Nicotinamide Mononucleotide Is Safe and Efficiently Increases Blood Nicotinamide Adenine Dinucleotide Levels in Healthy Subjects.
    Okabe K, Yaku K, Uchida Y, Fukamizu Y, Sato T, Sakurai T, Tobe K, Nakagawa T.
    Front Nutr; 2022 Oct 24; 9():868640. PubMed ID: 35479740
    [Abstract] [Full Text] [Related]

  • 5. Nicotinamide adenine dinucleotide metabolism and arterial stiffness after long-term nicotinamide mononucleotide supplementation: a randomized, double-blind, placebo-controlled trial.
    Katayoshi T, Uehata S, Nakashima N, Nakajo T, Kitajima N, Kageyama M, Tsuji-Naito K.
    Sci Rep; 2023 Feb 16; 13(1):2786. PubMed ID: 36797393
    [Abstract] [Full Text] [Related]

  • 6. Safety and efficacy of long-term nicotinamide mononucleotide supplementation on metabolism, sleep, and nicotinamide adenine dinucleotide biosynthesis in healthy, middle-aged Japanese men.
    Yamaguchi S, Irie J, Mitsuishi M, Uchino Y, Nakaya H, Takemura R, Inagaki E, Kosugi S, Okano H, Yasui M, Tsubota K, Hayashi K, Yoshino J, Itoh H.
    Endocr J; 2024 Feb 28; 71(2):153-169. PubMed ID: 38191197
    [Abstract] [Full Text] [Related]

  • 7. MIB-626, an Oral Formulation of a Microcrystalline Unique Polymorph of β-Nicotinamide Mononucleotide, Increases Circulating Nicotinamide Adenine Dinucleotide and its Metabolome in Middle-Aged and Older Adults.
    Pencina KM, Lavu S, Dos Santos M, Beleva YM, Cheng M, Livingston D, Bhasin S.
    J Gerontol A Biol Sci Med Sci; 2023 Jan 26; 78(1):90-96. PubMed ID: 35182418
    [Abstract] [Full Text] [Related]

  • 8. Effect of oral administration of nicotinamide mononucleotide on clinical parameters and nicotinamide metabolite levels in healthy Japanese men.
    Irie J, Inagaki E, Fujita M, Nakaya H, Mitsuishi M, Yamaguchi S, Yamashita K, Shigaki S, Ono T, Yukioka H, Okano H, Nabeshima YI, Imai SI, Yasui M, Tsubota K, Itoh H.
    Endocr J; 2020 Feb 28; 67(2):153-160. PubMed ID: 31685720
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Chronic nicotinamide mononucleotide supplementation elevates blood nicotinamide adenine dinucleotide levels and alters muscle function in healthy older men.
    Igarashi M, Nakagawa-Nagahama Y, Miura M, Kashiwabara K, Yaku K, Sawada M, Sekine R, Fukamizu Y, Sato T, Sakurai T, Sato J, Ino K, Kubota N, Nakagawa T, Kadowaki T, Yamauchi T.
    NPJ Aging; 2022 May 01; 8(1):5. PubMed ID: 35927255
    [Abstract] [Full Text] [Related]

  • 11. Oral Administration of Nicotinamide Mononucleotide Increases Nicotinamide Adenine Dinucleotide Level in an Animal Brain.
    Ramanathan C, Lackie T, Williams DH, Simone PS, Zhang Y, Bloomer RJ.
    Nutrients; 2022 Jan 12; 14(2):. PubMed ID: 35057482
    [Abstract] [Full Text] [Related]

  • 12. The Safety and Antiaging Effects of Nicotinamide Mononucleotide in Human Clinical Trials: an Update.
    Song Q, Zhou X, Xu K, Liu S, Zhu X, Yang J.
    Adv Nutr; 2023 Nov 12; 14(6):1416-1435. PubMed ID: 37619764
    [Abstract] [Full Text] [Related]

  • 13. Towards personalized nicotinamide mononucleotide (NMN) supplementation: Nicotinamide adenine dinucleotide (NAD) concentration.
    Kuerec AH, Wang W, Yi L, Tao R, Lin Z, Vaidya A, Pendse S, Thasma S, Andhalkar N, Avhad G, Kumbhar V, Maier AB.
    Mech Ageing Dev; 2024 Apr 12; 218():111917. PubMed ID: 38430946
    [Abstract] [Full Text] [Related]

  • 14. Safety evaluation after acute and sub-chronic oral administration of high purity nicotinamide mononucleotide (NMN-C®) in Sprague-Dawley rats.
    Cros C, Cannelle H, Laganier L, Grozio A, Canault M.
    Food Chem Toxicol; 2021 Apr 12; 150():112060. PubMed ID: 33587977
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Nicotinamide mononucleotide supplementation enhances aerobic capacity in amateur runners: a randomized, double-blind study.
    Liao B, Zhao Y, Wang D, Zhang X, Hao X, Hu M.
    J Int Soc Sports Nutr; 2021 Jul 08; 18(1):54. PubMed ID: 34238308
    [Abstract] [Full Text] [Related]

  • 17. Effects of nicotinamide mononucleotide on older patients with diabetes and impaired physical performance: A prospective, placebo-controlled, double-blind study.
    Akasaka H, Nakagami H, Sugimoto K, Yasunobe Y, Minami T, Fujimoto T, Yamamoto K, Hara C, Shiraki A, Nishida K, Asano K, Kanou M, Yamana K, Imai SI, Rakugi H.
    Geriatr Gerontol Int; 2023 Jan 08; 23(1):38-43. PubMed ID: 36443648
    [Abstract] [Full Text] [Related]

  • 18. Host-microbiome interactions in nicotinamide mononucleotide (NMN) deamidation.
    Kim LJ, Chalmers TJ, Madawala R, Smith GC, Li C, Das A, Poon EWK, Wang J, Tucker SP, Sinclair DA, Quek LE, Wu LE.
    FEBS Lett; 2023 Sep 08; 597(17):2196-2220. PubMed ID: 37463842
    [Abstract] [Full Text] [Related]

  • 19. Nicotinamide mononucleotide (NMN) as an anti-aging health product - Promises and safety concerns.
    Nadeeshani H, Li J, Ying T, Zhang B, Lu J.
    J Adv Res; 2022 Mar 08; 37():267-278. PubMed ID: 35499054
    [Abstract] [Full Text] [Related]

  • 20. Long-Term Administration of Nicotinamide Mononucleotide Mitigates Age-Associated Physiological Decline in Mice.
    Mills KF, Yoshida S, Stein LR, Grozio A, Kubota S, Sasaki Y, Redpath P, Migaud ME, Apte RS, Uchida K, Yoshino J, Imai SI.
    Cell Metab; 2016 Dec 13; 24(6):795-806. PubMed ID: 28068222
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.